September 2, 2026
FDA Criticized for Inaction as Black Market for Unapproved Weight-Loss Drug Retatrutide Flourishes Online
September 1, 2026
Harrisburg Hematologist Dr. Salman Fazal Earns Third Consecutive Castle Connolly Top Doctor Honor
August 30, 2026
Nurse’s Metastatic Breast Cancer Journey Highlights Importance of New Treatment Options
August 28, 2026
New Study Challenges Core Safety Assumption of Electroshock Therapy, CCHR Renews Ban Calls
August 26, 2026
Heidelberg Pharma and Huadong Medicine Secure NMPA Approval for HDP-101 Combination Trial in China
August 25, 2026
Lakewood-Amedex Biotherapeutics Partners with B2i Digital Ahead of Phase 2a Trial for Infected Diabetic Foot Ulcers
August 25, 2026
Citius Pharmaceuticals Leverages FDA-Approved LYMPHIR and Late-Stage Pipeline to Drive Growth
August 24, 2026
VERAXA and Secarna Report Positive Early Data in Antibody-Oligonucleotide Collaboration
August 24, 2026
VERAXA Biotech Advances VXA-222 Cancer Program Beyond Discovery Phase, Strengthens IP Portfolio
August 24, 2026
Scinai Immunotherapeutics Reports H1 2026 Results, Advances U.S. Clinical Manufacturing Program
August 23, 2026
New Seven Up Score Could Spare One in Three Liver Transplant Patients from Unnecessary Steroid Treatment
August 23, 2026
Mitochondrial Transplantation During Machine Perfusion Shows Promise for Repairing Donor Organs
August 19, 2026
Quantum BioPharma’s Lucid-MS Targets Myelin Protection as New Approach to MS Treatment
August 19, 2026
Quantum BioPharma’s Lucid-MS Advances Toward Phase 2 Trials as MS Treatment Focus Expands Beyond Inflammation
August 18, 2026
Regentis Biomaterials Secures Japanese Patent for GelrinC Manufacturing, Boosting Commercialization Prospects
August 18, 2026
American Heart Association Opens 2026 Health Tech Competition to Accelerate Cardiovascular and Brain Health Innovations
August 17, 2026
Helix BioPharma Appoints Dr. Markus Loeffler as Chief Medical Officer to Drive Next Phase of Oncology Clinical Development
August 17, 2026
Regentis Biomaterials Advances GelrinC on Parallel U.S. Clinical and European Commercial Paths
August 17, 2026
Alpha Cognition’s ZUNVEYL Demand Surges, Setting Stage for Growth Despite Payer Headwinds
August 14, 2026
Onco-Innovations Advances ONC010 Toward First-in-Human Trials with Key Manufacturing and Metabolic Studies
August 14, 2026
Regentis Biomaterials Advances GelrinC as Off-the-Shelf Option in Knee Cartilage Repair Market
August 14, 2026
Quantum BioPharma Cuts Costs, Advances Multiple Sclerosis Drug to Phase 2 After FDA Approval
August 14, 2026
Regentis Biomaterials Advances GelrinC with Parallel U.S. Clinical and European Commercial Strategies
August 14, 2026
Helus Pharma Completes Enrollment in Pivotal Phase 3 Depression Trial, Targets Q4 2026 Data
August 13, 2026
NeOnc’s NEO100 Shows Strong Survival Signal in Phase 2a, Paving Way for Regulatory Discussions
August 13, 2026
PX1 Research Releases USA-Made Retatrutide and Tirzepatide Peptides with 99%+ Purity Verified by HPLC
August 13, 2026
Quantum BioPharma’s Lucid-MS Targets Disability Drivers Beyond Relapse in Multiple Sclerosis
August 13, 2026
Nutriband CEO to Spotlight Abuse-Deterrent Patch Technology at Georgia Life Sciences Summit
